Bacterial 50S ribosomal subunit peptidyl transferase center and nascent polypeptide exit tunnel (50S PTC/NPET)

The bacterial 50S ribosomal subunit is the larger component of the prokaryotic 70S ribosome and serves as the primary site for the catalytic steps of protein synthesis. It contains two essential functional regions: the peptidyl transferase center (PTC) and the nascent polypeptide exit tunnel (NPET) [1.1.1, 1.5.2]. The PTC is a ribozyme composed of 23S rRNA that catalyzes the formation of peptide bonds between amino acids, while the NPET provides a protected path for the newly synthesized protein to emerge from the ribosome [1.4.1, 1.4.4]. This target is the site of action for several major antibiotic classes, including macrolides, lincosamides, oxazolidinones, and pleuromutilins [1.3.3, 1.5.1]. These drugs inhibit translation by either sterically blocking the PTC to prevent peptide bond formation or obstructing the NPET to halt the elongation of the nascent polypeptide chain [1.3.1, 1.5.3]. Due to the evolutionary conservation between bacterial ribosomes and human mitochondrial ribosomes, certain drugs targeting this site can cause off-target mitochondrial toxicity, leading to clinical side effects such as myelosuppression and neuropathy [1.2.1, 1.2.3]. The emergence of resistance, often through rRNA methylation or specific mutations in the 23S rRNA, remains a significant challenge in treating bacterial infections [1.3.3, 1.5.4]. Understanding the structural nuances of the 50S subunit is essential for developing next-generation antibiotics that can overcome these resistance pathways.

Other names

50S peptidyl transferase centerNascent polypeptide exit tunnelNPETPTCLarge ribosomal subunit23S rRNA peptidyl transferase center50S ribosomal subunit

Drugs targeting this site inhibit bacterial protein synthesis by binding to the 23S rRNA. PTC-binding drugs (e.g., chloramphenicol, lincosamides) prevent peptide bond formation by sterically hindering tRNA positioning, while NPET-binding drugs (e.g., macrolides) block the exit tunnel, causing the premature release of the nascent polypeptide chain [1.1.2, 1.3.1, 1.5.3].